Trading as PPHDA from today. So lst close of $6.80 should now equate to $1.70 per PPHDA unless this thing drops further due to a complete lack of interest by investors.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%